Newsroom

LOS ANGELES--(BUSINESS WIRE)--XTIA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against XTI Aerospace, Inc....

NEW YORK--(BUSINESS WIRE)--Destiny Tech100 Inc. (NYSE: DXYZ) today announced financial results for the quarter ended June 30, 2026. The fund reported a net asset value (NAV) of $34.30 per share of common stock, up from $24.56 per share at the end of the first quarter of 2026.As of June 30, 2026, Destiny Tech100’s investment portfolio had an aggregate fair value of approximately $1.64 billion, including short-term investments. The fund maintains positions in a variety of privately-held technology...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Noalan v. XTI Aerospace, Inc. et al., Case No. 26-cv-07378, on behalf of persons and entities that purchased or otherwise acquired XTI Aerospace, Inc. (“XTI Aerospace” or the “Company”) (NASDAQ: XTIA) securities between April 15, 2026 and August 17, 2026, inclusive (the “Class Period”)...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Labed v. Innventure, Inc. et al., Case No. 26-cv-07377, on behalf of persons and entities that purchased or otherwise acquired Innventure, Inc. (“Innventure” or the “Company”) (NASDAQ: INV) securities between November 17, 2025 and August 13, 2026, inclusive (the “Class Period”). Plaint...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, filiale de Rigaku Holdings et un partenaire mondial spécialisé dans les solutions pour systèmes d’analyse par rayons X (siège social : Akishima, Tokyo ; PDG : Jun Kawakami ; ci-après « Rigaku »), et l’Université de Tohoku (Sendai, préfecture de Miyagi ; président : Teiji Tominaga ; ci-après « l’Université de Tohoku ») ont créé, le 1er août 2026, le Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology : Beyond The Limits (ci-aprè...

SAN FRANCISCO--(BUSINESS WIRE)--Innolitics, a medical-device software and FDA regulatory services provider, and BEACON-Neuro.AI Inc., a Washington University in St. Louis startup, today announced the partnership behind BEACONPredict, AI software for predicting malignant cerebral edema risk after acute ischemic stroke. Innolitics brought the regulatory strategy and software engineering; BEACON-Neuro.AI brought the clinical science out of Dr. Raj Dhar's neurocritical-care lab at WashU Medicine. T...

TOKIO--(BUSINESS WIRE)--Rigaku Corporation, empresa del grupo Rigaku Holdings especializada en soluciones de análisis por rayos X a nivel mundial (sede central: Akishima, Tokio; presidente y director ejecutivo: Jun Kawakami; en adelante, «Rigaku»), y la Universidad de Tohoku (Sendai, Miyagi; presidente: Teiji Tominaga; en adelante, «Universidad de Tohoku») crearon el Instituto de Investigación Conjunta Rigaku–Universidad de Tohoku para la metrología por rayos X: Beyond The Limits (el «Instituto...

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a...

BEAVERTON, Ore.--(BUSINESS WIRE)--NIKE, Inc. (NYSE: NKE) plans to release its first quarter fiscal 2027 financial results on Thursday, October 1, 2026, at approximately 1:15 p.m. PT, following the close of regular stock market trading hours. Following the news release, NIKE, Inc. management will host a conference call beginning at 2:00 p.m. PT to review results.The conference call will be broadcast live over the Internet and can be accessed at https://investors.nike.com/. For those unable to lis...